Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial Randomized to Evaluate the Interest of Hyaluronic Acid in the Preservation of Sexual Function During Prostate Curietherapies

NCT04105920 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT04105920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04105920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial Randomized to Evaluate the Interest of Hyaluronic Acid in the Preservation of Sexual Function During Prostate Curietherapies
Lead sponsor
Hospices Civils de Lyon
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 5, 2021
Completion date
April 5, 2027
Enrollment
162 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer